These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10904980)

  • 21. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
    Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
    Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nephrolithiasis and topiramate].
    Alarcón-Martínez H; Casas-Fernández C; Escudero-Rodríguez N; Cao-Avellaneda E; Domingo-Jiménez R; Puche-Mira A; Rodríguez-Costa T
    Rev Neurol; 2006 Jan 16-31; 42(2):91-4. PubMed ID: 16450323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topiramate and metabolic acidosis in pediatric epilepsy.
    Takeoka M; Holmes GL; Thiele E; Bourgeois BF; Helmers SL; Duffy FH; Riviello JJ
    Epilepsia; 2001 Mar; 42(3):387-92. PubMed ID: 11442157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-up.
    Kim JM; Kwon S; Seo HE; Choe BH; Cho MH; Park SP
    J Korean Med Sci; 2009 Dec; 24(6):1078-82. PubMed ID: 19949663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of topiramate: a review.
    Garnett WR
    Epilepsia; 2000; 41(S1):61-5. PubMed ID: 10768303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of topiramate in infants according to epilepsy syndromes.
    Grosso S; Galimberti D; Farnetani MA; Cioni M; Mostardini R; Vivarelli R; Di Bartolo RM; Bernardoni E; Berardi R; Morgese G; Balestri P
    Seizure; 2005 Apr; 14(3):183-9. PubMed ID: 15797353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacy clinics. Medication of the month. Topiramate (Topamax)].
    Sadzot B
    Rev Med Liege; 2000 Feb; 55(2):114-6. PubMed ID: 10769582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study of topiramate in children with Lennox-Gastaut syndrome.
    Guerreiro MM; Manreza ML; Scotoni AE; Silva EA; Guerreiro CA; Souza EA; Ferreira VB; Reed UC; Diament A; Trefiglio R; Chiu HC; Bacaltchuk J
    Arq Neuropsiquiatr; 1999 Jun; 57(2A):167-75. PubMed ID: 10412513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacological and clinical review on topiramate, a new antiepileptic drug.
    Perucca E
    Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate in frontal lobe epilepsy.
    Verrotti A; Sofia V; Franzoni E; Coppola G; Manco R; Ciambra GL; Savasta S; Chiarelli F; Iannetti P
    Acta Neurol Scand; 2007 Feb; 115(2):132-5. PubMed ID: 17212619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy.
    Takeoka M; Riviello JJ; Pfeifer H; Thiele EA
    Epilepsia; 2002 Sep; 43(9):1072-5. PubMed ID: 12199733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of body weight and galanin in epileptic children treated with topiramate].
    Shi RF; Wang KL; Li QH; Zheng HC; Yang HF; Tang HX; Sun SZ; Wang LH; Tian J
    Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):199-202. PubMed ID: 17504624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible language regression as an adverse effect of topiramate treatment in children.
    Gross-Tsur V; Shalev RS
    Neurology; 2004 Jan; 62(2):299-300. PubMed ID: 14745074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topiramate for epilepsy.
    Med Lett Drugs Ther; 1997 May; 39(1001):51-2. PubMed ID: 9164447
    [No Abstract]   [Full Text] [Related]  

  • 36. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy.
    Russo E; Constanti A; Ferreri G; Citraro R; De Sarro G
    Neuropharmacology; 2004 May; 46(6):865-78. PubMed ID: 15033346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of topiramate used with conventional schemes as an adjunctive therapy in the treatment of Lennox-Gastaut syndrome].
    Alva-Moncayo E; Ruiz-Ruiz A
    Rev Neurol; 2003 Mar 1-15; 36(5):453-7. PubMed ID: 12640599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate and psychiatric adverse events in patients with epilepsy.
    Mula M; Trimble MR; Lhatoo SD; Sander JW
    Epilepsia; 2003 May; 44(5):659-63. PubMed ID: 12752464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
    Mula M; Trimble MR; Sander JW
    Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.